| Joseph A Lash, MD | |
|
6420 Dutchmans Pkwy, Suite 200, Louisville, KY 40205-3372 | |
| (502) 891-8300 | |
| (502) 891-8338 |
| Full Name | Joseph A Lash |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 42 Years |
| Location | 6420 Dutchmans Pkwy, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023040680 | NPI | - | NPPES |
| 50031147 | Other | KY | PASSPORT- CARDIOTHORACIC SURGERY OF LOUISVILLE |
| 000000044907 | Other | KY | ANTHEM PIN |
| 000057080J | Other | KY | HUMANA- CTS |
| 2433841000 | Other | KY | PASSPORT ADVANTAGE PIN |
| 1056117 | Other | KY | PASSPORT PIN |
| P00893013 | Other | KY | RAILROAD MEDICARE- CTS |
| 100388590A | Medicaid | IN | |
| 000000693035 | Other | KY | ANTHEM- CTS |
| 100388590F | Medicaid | IN | |
| 64282817 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 28281 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Medical Associates Inc | 7012811284 | 1098 |
News Archive
CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009.
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients with the disease, according to a study at The University of Texas MD Anderson Cancer Center.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced positive clinical data with the Company's IMGN901 (lorvotuzumab mertansine) product candidate as featured in an oral presentation at the ASCO 2011 Annual Meeting in Chicago.
Novartis will highlight more than 250 abstracts demonstrating advances in blood and breast cancer research at the upcoming American Society of Hematology (ASH) annual meeting December 6-9, and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) December 9-13.
Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need - especially women and minorities, say researchers at Duke University Medical Center.
› Verified 6 days ago
| Entity Name | Community Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588614994 PECOS PAC ID: 7012811284 Enrollment ID: O20031120000656 |
News Archive
CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009.
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients with the disease, according to a study at The University of Texas MD Anderson Cancer Center.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced positive clinical data with the Company's IMGN901 (lorvotuzumab mertansine) product candidate as featured in an oral presentation at the ASCO 2011 Annual Meeting in Chicago.
Novartis will highlight more than 250 abstracts demonstrating advances in blood and breast cancer research at the upcoming American Society of Hematology (ASH) annual meeting December 6-9, and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) December 9-13.
Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need - especially women and minorities, say researchers at Duke University Medical Center.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph A Lash, MD Po Box 950202, Louisville, KY 40295-0202 Ph: (502) 588-9490 | Joseph A Lash, MD 6420 Dutchmans Pkwy, Suite 200, Louisville, KY 40205-3372 Ph: (502) 891-8300 |
News Archive
CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009.
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients with the disease, according to a study at The University of Texas MD Anderson Cancer Center.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced positive clinical data with the Company's IMGN901 (lorvotuzumab mertansine) product candidate as featured in an oral presentation at the ASCO 2011 Annual Meeting in Chicago.
Novartis will highlight more than 250 abstracts demonstrating advances in blood and breast cancer research at the upcoming American Society of Hematology (ASH) annual meeting December 6-9, and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) December 9-13.
Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need - especially women and minorities, say researchers at Duke University Medical Center.
› Verified 6 days ago
Cindy J Code, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3950 Kresge Way, Suite 303, Louisville, KY 40207 Phone: 502-896-1880 Fax: 502-896-1887 | |
Dr. Uchenna Loretta Ozor, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 E Chestnut St Bldg Suite303, Louisville, KY 40202 Phone: 502-629-5552 Fax: 502-629-3132 | |
Mohamed Hegazi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 529 S Jackson St, Louisville, KY 40202 Phone: 502-562-4270 | |
Dr. Michael Patrick Krease, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1169 Eastern Pkwy Ste G58, Louisville, KY 40217 Phone: 502-452-9567 | |
Dr. Ramsey Nasri Nassar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6400 Dutchmans Pkwy, Ste 250, Louisville, KY 40205 Phone: 502-587-9660 Fax: 502-540-5615 | |
Jeanne M Thompson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Audubon Plaza Dr, Ll2, Louisville, KY 40217 Phone: 502-636-8095 Fax: 502-636-8097 | |
Terrence P Donohue, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3101 Poplar Level Rd Ste 101, Louisville, KY 40213 Phone: 502-636-7444 Fax: 502-636-7112 |